Skip to main content

Table 1 Patient characteristics and body composition measures among the four groups

From: The effects of the administration sequence and the type of hypnotics on the development of remifentanil-induced chest wall rigidity: a randomized controlled trial

 

Thio-Remi

(n = 30)

Pro-Remi

(n = 30)

Remi-Thio

(n = 30)

Remi-Pro

(n = 30)

P value

Age (years)

68.7 (4.7)

71.4 (5.9)

70.5 (5.2)

71.0 (6.1)

0.257

65–75 years

26

24

24

23

0.796

\(\ge\) 75 years

4

6

6

7

 

Female [n (%)]

14 (46.7%)

22 (73.3%)

18 (60.0%)

19 (63.3%)

0.205

Height (cm)

159.0 (9.3)

156.2 (6.0)

156.7 (9.5)

158.2 (7.7)

0.523

Weight (kg)

65.5 (9.9)

60.1 (9.1)

59.6 (9.8)

60.9 (11.7)

0.099

BMI (kg/m2)

25.9 (3.2)

24.7 (3.6)

24.2 (2.4)

24.2 (3.6)

0.134

Body fat mass (kg)

18.1 (6.3)

16.8 (6.7)

16.2 (4.9)

16.2 (7.1)

0.657

Percent body fat (%)

27.4 (9.3)

27.7 (7.9)

27.8 (8.6)

26.1 (9.0)

0.858

Skeletal muscle mass (kg)

26.6 (6.0)

23.3 (4.4)

23.4 (6.2)

24.3 (5.1)

0.098

Skeletal muscle index (kg/m2)

8.4 (1.2)

7.7 (1.2)

7.5 (1.5)

7.7 (1.2)

0.049*

Total body water (L)

35.6 (7.2)

31.7 (5.5)

31.8 (7.7)

32.9 (6.3)

0.110

Underlying diseases [n (%)]

 Hypertension

15 (50.0%)

11 (36.7%)

16 (53.3%)

13 (43.3%)

0.576

 Diabetes mellitus

4 (13.3%)

4 (13.3%)

8 (26.7%)

4 (13.3%)

0.410

  1. Values are presented as means (SD), numbers, or numbers (percentages)
  2. BMI Body mass index
  3. *There were no significant differences based on multiple comparisons with Tukey’s post-hoc test